Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
19-May-2017Pharmacological characterization Of Maba, Gsk961081 on human airway smooth muscle cellsBhavsar, PK; Sehra, G; Johnson, M; Chung, K; GlaxoSmithKline Services Unlimited
8-Nov-2016Risk of myocardial infarction (MI) associated with acute exacerbations of COPD (AECOPD): effects of exacerbation frequencyRothnie, K; Mullerova, H; Smeeth, L; Pearce, N; Douglas, I, et al
25-Aug-2016Risk of myocardial infarction (MI) associated with acute exacerbations of COPD (AECOPD): effect modification by cardiovascular drugsRothnie, K; Mullerova, H; Smeeth, L; Pearce, N; Douglas, I, et al
1-Aug-2015THE IMPACT OF DRUG CLEARANCE ON DURATION OF ACTION OF CORTICOSTEROIDSHakim, A; Barnes, PJ; Adcock, IM; Usmani, OS; GlaxoSmithKline Services Unlimited
2-Dec-2015Recording of hospitalisations for acute exacerbations of copd in uk electronic healthcare records databasesRothnie, KJ; Mullerova, H; Hurst, JR; Smeeth, L; Chandan, J, et al
19-May-2017Acute exacerbations of COPD: Natural history and effect of frequency and severity on risk of deathRothnie, K; Müllerová, H; Quint, JK; GlaxoSmithKline Services Unlimited
2-Dec-2015VALIDITY AND INTERPRETATION OF SPIROMETRY FOR PATIENTS IN PRIMARY CARERothnie, KJ; Mullerova, H; Goss, H; Chandan, J; Quint, JK, et al